Try our corporate solution for free!

Oncology or orphan drug share in approved new active substances 2015-2020

Share of orphan or oncology drugs among approved new active substances (NAS) in select developed countries from 2015 to 2020

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Single Account

$39 $59 per month *
in the first 12 months
33% off until Jun 30th
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2022

Region

Worldwide

Survey time period

2015 to 2020

Supplementary notes

Includes drugs launched in Canada, France, Germany, Italy, Sweden, Switzerland, United Kingdom and the United States.

Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on "Orphan drugs"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.